Composite

Part:BBa_K3813025

Designed by: Yamato Okura   Group: iGEM21_ASIJ_Tokyo   (2021-09-17)


Mammaglobin-B(SCGB2A1) with optimized TA promoter and T1 terminator

Part Info

This part can be used to initiate the production of the Mammaglobin-B biomarker(protein) in an E.Coli cell system. Mammaglobin-B is an essential biomarker that is beneficial towards the detection of breast cancer. We decided to synthesize Mammaglobin-B in E.Coli in order to model biomarkers in human breast tissue and apply this for our aptamer experiments.

Construct Design

This is a composite part made up of a combination of previously existing parts from the iGEM registry: optimized (TA) repeat constitutive promoter(BBa_K137085) and T1 terminator(BBa_B0010) RBS along with the Mammaglobin-B gene sequence from NCBI.


Results

We selected the forward and reverse primers for our Mammaglobin-B protein sequence.

SCGB2A1 Forward Primer 5′-AAACTCCTGGAGGACATGGTT-3′ Reverse Primer5′-ACTGCTTGAATTTCCCCATAGC-3′

We first used PCR to amplify our protein-coding sequence(found on NCBI) and selected our forward and reverse primers based on an extensive literature review we performed.

We then used Gibson Assembly to construct our part in the iGEM chloramphenicol backbone pSB1C3, before transforming it into E.Coli cells. We used a GFP reporter in our construct to monitor if the Mammaglobin-B sequence was successfully expressed in our E.Coli cells. Following transformation, we first qualitatively analyzed the plates to see if they were glowing. Since our construct was tagged with GFP, if the biomarker was successfully produced, then our colonies would glow.

Our qualitative analysis observed that there were glowing colonies on all parts of the plate, with relatively large colonies.

T--ASIJ_Tokyo--C6.png

Figure 1: Transformation Results for BBa K3813025. The glowing colonies seen in the picture represent that Mammaglobin-B was successfully expressed in the system and that we could quantitatively analyze for the amount of protein produced through purification.

Protein Expression and Purification

To further verify our findings, we purified the Mammaglobin-B that was produced through transformation by applying freezing/cracking before using the regular purification process. This was because the Mammaglobin-B sequence was relatively large and without a tag, it was difficult to extract the protein out through regular purification. PAGE electrophoresis and readings from the 96-well plate reader indicated the presence of Mammaglobin-B from this construct.

Analysis of Protein Concentration

To calculate the concentrations of the biomarkers within each well, we first ran the BSA model to create the standard curve, where the x-axis represents absorbance, and y-axis represents the concentration in mg/ml. The standard curve later allowed us to convert the measured absorbance into measurements of concentration. The equation and the image of the standard graph we derived from the BSA model is as follows.

T--ASIJ_Tokyo--BSA_Standard.png

Figure 2: Standard Curve for BSA

Using the standard curve and the measured absorbance, we interpolated values of concentration for each of the different constructs. We performed this conversion by substituting the absorbance values into the x-variable in our standard curve, to find the corresponding y-variable which represents concentration. The post-conversion concentrations of the biomarkers are listed below.

For construct BBa_K3813025, we had a reading of 0.40 mg/ml for the concentration of biomarker synthesized. For Mammaglobin-B, this was our most successful construct and indicates the versatility of the optimized (TA) repeat constitutive promoter and T1 terminator. Since the concentration of Mammaglobin-B was high for this construct, we plan on utilizing this for our aptamer-based experiments.

References

[1] Wang, Y., Kirpich, I., Liu, Y., Ma, Z., Barve, S., McClain, C. J., & Feng, W. (2011). Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. The American Journal of Pathology, 179(6), 2866–2875.

[2] Homo sapiens chromosome 11, GRCh38.p13 Primary Assembly - Nucleotide - NCBI. (n.d.). Retrieved August 2, 2021, from https://www.ncbi.nlm.nih.gov/nuccore/NC_000011.10?report=fasta&from=62270130&to=62273160


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 26
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
Parameters
None